University Hospital, Montpellier, France; MACVIA-France, Fondation partenariale FMC VIA-LR, Montpellier, France; VIMA, INSERM U 1168, VIMA: Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny-le-Bretonneux, and Euforea, Brussels, Belgium.
Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
J Allergy Clin Immunol. 2019 Mar;143(3):864-879. doi: 10.1016/j.jaci.2018.08.049. Epub 2018 Sep 29.
Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline by using the best approach to integrated care pathways using mobile technology in patients with allergic rhinitis (AR) and asthma multimorbidity. The proposed next phase of ARIA is change management, with the aim of providing an active and healthy life to patients with rhinitis and to those with asthma multimorbidity across the lifecycle irrespective of their sex or socioeconomic status to reduce health and social inequities incurred by the disease. ARIA has followed the 8-step model of Kotter to assess and implement the effect of rhinitis on asthma multimorbidity and to propose multimorbid guidelines. A second change management strategy is proposed by ARIA Phase 4 to increase self-medication and shared decision making in rhinitis and asthma multimorbidity. An innovation of ARIA has been the development and validation of information technology evidence-based tools (Mobile Airways Sentinel Network [MASK]) that can inform patient decisions on the basis of a self-care plan proposed by the health care professional.
变应性鼻炎及其对哮喘的影响 (ARIA) 已经从使用最佳方法通过移动技术为变应性鼻炎 (AR) 和哮喘多种病症患者整合护理路径的指南发展而来。ARIA 提出的下一个阶段是变更管理,目的是为鼻炎患者和哮喘多种病症患者在整个生命周期内提供积极和健康的生活,无论其性别或社会经济地位如何,以减少因疾病而导致的健康和社会不平等。ARIA 遵循 Kotter 的 8 步模型来评估和实施鼻炎对哮喘多种病症的影响,并提出多种病症指南。ARIA 第 4 阶段提出了第二个变更管理策略,以增加在鼻炎和哮喘多种病症中的自我用药和共同决策。ARIA 的一项创新是开发和验证基于信息技术的循证工具(移动气道哨兵网络 [MASK]),该工具可以根据医疗保健专业人员提出的自我护理计划为患者做出决策提供信息。